| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.46 | 0.06 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.06 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.054 | 0.06 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.07 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.07 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.086 | 0.07 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.4 | 0.07 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.096 | 0.07 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.07 |